How to Assess Extubation Readiness in Pediatrics
Use a protocolized extubation readiness testing (ERT) bundle that includes daily screening, a spontaneous breathing trial (SBT), sedation assessment, evaluation of secretion management, and consideration of upper airway obstruction risk—this structured approach reduces extubation failure rates and improves outcomes. 1
Core Framework: The ERT Bundle Approach
The 2023 PALISI international guidelines establish that extubation readiness assessment should follow a systematic, protocolized approach rather than relying solely on clinical judgment 1. This bundle-based strategy has been shown to reduce extubation failure rates from 12.9% to 2.4% when properly implemented 2.
Step 1: Daily Safety Screening (Eligibility Assessment)
Before proceeding with formal testing, verify the child meets these safety criteria 1:
- Gas exchange: Adequate oxygenation on acceptable FiO₂ (typically ≤0.5)
- Hemodynamic stability: No active shock, stable vasoactive support
- Neurologic status: Appropriate level of consciousness for age
- No planned procedures requiring sedation in next 12-24 hours
- Ventilator settings: Reasonable support levels (consider mean airway pressure >10 cm H₂O as a negative predictor) 3
Step 2: Sedation and Airway Assessment
Evaluate three critical elements before proceeding 1:
- Sedation level: Use a validated sedation scale (e.g., COMFORT-B, State Behavioral Scale) to ensure appropriate arousal—not too deep, not agitated 1
- Cough effectiveness: Must demonstrate adequate cough strength to clear secretions
- Secretion management: Assess volume and character of endotracheal and oropharyngeal secretions—60% of providers delay extubation for significant secretions 4
Critical pitfall: Approximately 60% of pediatric cardiac ICUs do not consistently use validated sedation scales 4, yet sedation assessment is a core component of safe extubation.
Step 3: Spontaneous Breathing Trial (SBT)
Perform an SBT as the objective centerpiece of extubation readiness assessment 1:
SBT Method Selection:
- Standard-risk patients: Use either pressure support (PS) with CPAP OR CPAP alone 1
- High-risk patients (see Table 4 criteria below): Use CPAP alone WITHOUT pressure support—PS augmentation underestimates post-extubation work of breathing and may lead to premature extubation 1
SBT Duration:
- Standard-risk patients: 30 minutes is acceptable 1
- High-risk patients: 60-120 minutes provides better assessment 1
High-risk populations include 1:
- Younger age (especially <1 year)
- Prolonged mechanical ventilation
- Cardiac disease
- Neuromuscular conditions
- Chronic lung disease
- Obesity
Step 4: Respiratory Muscle Strength Assessment
Measure maximal inspiratory pressure (PiMax) in children at risk for muscle weakness or extubation failure 1. Risk factors include:
- Prolonged mechanical ventilation
- Neuromuscular disease
- Prolonged corticosteroid or neuromuscular blocker use
- Sepsis
- Malnutrition
- Chronic illness
While specific pediatric thresholds are not well-established, recent data suggests diaphragmatic excursion >5.5 mm on ultrasound (sensitivity 100%, specificity 91.7%) and diaphragmatic thickening fraction >29% are the strongest predictors of extubation success 5.
Emerging evidence: The rapid shallow breathing index (RSBI) ≥4.62 breaths/min/mL/kg identifies children at increased risk of extubation failure after cardiac surgery (sensitivity 84.6%, specificity 94.0%) 6.
Step 5: Upper Airway Obstruction (UAO) Risk Assessment
For children with cuffed endotracheal tubes, perform an air leak test 1:
High-risk UAO populations 1:
- Multiple intubation attempts
- Traumatic intubation
- Large-for-age endotracheal tube
- ETT air leak pressure >25 cm H₂O for cuffed tubes
- Anatomical airway anomalies
Corticosteroid Prophylaxis:
Administer dexamethasone at least 6 hours before extubation in high-risk children 1. Key points:
- Early administration (>6-12 hours pre-extubation) is more effective than late administration
- Both high-dose (>0.5 mg/kg) and low-dose regimens work when given early
- If given <6 hours before extubation, use higher doses (>0.5 mg/kg)
- Do not delay extubation to complete a dexamethasone course in standard-risk patients 1
The evidence shows dexamethasone reduces UAO incidence (205 fewer cases per 1,000 patients) but has unclear benefit on overall extubation failure rates 1.
Step 6: Post-Extubation Respiratory Support Planning
For high-risk patients, plan noninvasive respiratory support (NRS) immediately after extubation 1:
- Children <1 year: Use CPAP over high-flow nasal cannula (HFNC) 1
- Older children: HFNC, CPAP, or NIV are all acceptable
- If respiratory distress develops on conventional oxygen: Escalate to NRS rather than continuing conventional therapy 1
This approach is supported by 91.9% of providers using HFNC as their primary noninvasive support method 4.
Practical Implementation Algorithm
12-24 hours before anticipated extubation:
- For cuffed ETT: Measure air leak pressure
- If leak pressure >25 cm H₂O or high UAO risk: Give dexamethasone
On day of extubation:
- Perform safety screening (gas exchange, hemodynamics, neurologic status, ventilator settings)
- Assess sedation with validated tool
- Evaluate cough and secretions
- If all pass → Proceed to SBT
- Measure PiMax if muscle weakness risk
- Conduct SBT (method and duration based on risk stratification)
- If SBT passes → Extubate to appropriate respiratory support
If safety screening fails:
- From cardiopulmonary perspective: Repeat in 12-24 hours
- From sedation perspective: Optimize sedation, repeat in 12-24 hours
Critical Nuances and Pitfalls
Variability in practice remains substantial despite guidelines—only 43.7% of pediatric cardiac ICU providers routinely perform SBTs, and 39.8% do not use validated sedation scales 4. This variability likely contributes to inconsistent outcomes.
The evidence quality is limited: Most recommendations carry "very low certainty of evidence" with conditional strength 1. However, the bundle approach represents best available evidence and expert consensus.
Extubation failure definitions vary: Most define it as reintubation within 24-48 hours 7, 4, though some studies use longer timeframes. The 48-hour window is most commonly used in practice.
Special populations require modified approaches: Children with congenital heart disease, particularly those with single-ventricle physiology or cyanotic lesions, may require more intensive assessment, though cyanotic lesions alone do not predict ERT failure 3.